Feryal Clark MP: speeches

77 published records · newest first.

Speeches

25 Jun 2025 · Topical Questions · Hansard source
More
The Government remain committed to ending the use of all animals, including dogs, in scientific procedures, replacing them with modern, human-relevant technologies. Our long-term goal, as set out in our 2024 manifesto commitment, is to phase out animal testing entirely. As my hon. Friend said, we will publish a detailed road map this year alongside convening roundtables with researchers, industry and animal welfare organisations to ensure that we achieve that and hit the target.
25 Jun 2025 · Topical Questions · Hansard source
More
My hon. Friend’s constituency is indeed a hotbed of innovation. She will be delighted to know that Healthtech-1 has benefited from a range of Government support to date, including a recent Innovate UK grant.
25 Jun 2025 · Online Safety: Children · Hansard source
More
I do indeed agree with my hon. Friend on that. Child sexual exploitation and abuse is one of the most horrendous harms, and the Government are committed to ensuring that UK law keeps pace with criminal use of technologies including AI. As he says, we have introduced a world-leading offence in the Crime and Policing Bill to criminalise AI models that have been optimised to create child sexual abuse material. This new offence builds on the protections in the Online Safety Act, and I am very clear that nothing is off the table when it comes to keeping our children safe.
25 Jun 2025 · Online Safety: Children · Hansard source
More
It was the hon. Gentleman’s party that dragged its feet in bringing forward the legislation and that watered it down. We are busy trying to implement the Act as it was set out in the guidance. While the Act is not perfect, we will see a huge step change. Where there are issues and gaps, we are not afraid to act.
25 Jun 2025 · Online Safety: Children · Hansard source
More
I thank the shadow Secretary of State for his question. The implementation is happening as set out and against the timeframe that was set out. As I said, we are not only busy implementing the Act, but looking at all the gaps that exist in it because Ministers in his Government watered down the Bill as it went through the House. We will review those gaps in the legislation and come forward with extra measures where they are needed.
25 Jun 2025 · Online Safety: Children · Hansard source
More
As the chair of the all-party parliamentary group on children’s online safety, my hon. Friend will know that keeping children safe online is a priority for this Government. We are focused on implementing the Online Safety Act 2023 so that children can benefit from its wide reach and protection. The children’s code that is coming in next month will see a step change in the experience of children online in the UK. While we do not pretend that that is job done, and we are working at pace to develop a further online safety package, children will no longer be able to access pornography or other unsuitable content, including content that encourages or promotes self-harm, eating disorders or suicide.
25 Jun 2025 · Online Safety: Children · Hansard source
More
I absolutely agree that some children are still stumbling upon material and content that they should not be. When the Online Safety Act is fully enacted in July, we will see a step change in what children can see online. Ofcom will monitor this and ensure that where such material is continuing, we take action.
25 Jun 2025 · Artificial Intelligence: Schools · Hansard source
More
AI has demonstrated that it can help the education workforce by reducing some of the administrative burdens and the hard work that teaching staff and school leaders face in their day-to-day role. On the hon. Gentleman’s question, evidence is still emerging on the benefits and risks of pupils and students using generative AI. We will continue to work with the education sector on use cases to develop our understanding of how to use AI safely and effectively. As I have said, the Department has issued guidance to teachers on how to identify and best use AI in schools.
25 Jun 2025 · Artificial Intelligence: Schools · Hansard source
More
As I have said, I work very closely with my counterparts in the Department for Education. Earlier this year, we launched safe standards for the sector and provided guidance on how to safely develop AI tools for education. The DFE has also provided guidance to schools on how to safely use AI in schools. That work is ongoing. As I have said, we are working both with the sector and with educators to make sure that we get this right.
25 Jun 2025 · Artificial Intelligence: Schools · Hansard source
More
My Department is working closely with the Department for Education and Skills England to ensure that the education system is ready for the opportunities and the challenges that AI poses. We are assessing the AI skills gap and mapping pathways to address it. My officials have been working closely with the DFE on the education content store, for example, which is a pilot project that seeks to help developers to make better AI tools for teachers by providing a store of reliable and relevant UK data. Last week, the DFE produced guidance to support schools with the safe and effective use of AI in education.
16 Jun 2025 · Animal Experiments: Medical Research · Hansard source
More
The road map will set out how we can get to a place where we can phase out animal testing. I cannot set out dates and what the road map will include, but a huge amount of investment is going into many of the projects that have been mentioned—hopefully that will all be included in the road map. As colleagues have said, where other nations are developing new ways to phase out animal testing, we will look into those and see where we can replicate them. We are closely following developments in Europe and the US, and we work closely with both the Food and Drug Administration and our European colleagues on this matter. Currently, the Government support the development and dissemination of the three Rs through UK Research and Innovation. That is primarily achieved through funding of the NC3Rs, which works nationally and internationally to drive the uptake of alternative technologies and to ensure that advances are reflected in policy, practice and regulation on animal testing. Since its launch in 2004, it has committed over £100 million through its research, innovation and early career awards to provide new three Rs approaches for scientists in academia and industry to use. That is only part of our support. Many UKRI programmes, including research on organoids, cell behaviour and AI, may eventually lead to the development of non-animal testing methods, but they are not categorised as such because they are basic research at the moment. The Government have also provided more than £6 million of funding for seven centres of excellence for regulatory science and innovation to help drive advancement in healthcare. The in-silico CERSI, led by the University of Manchester, aims to support the use of computational techniques to test and develop medical products. To be clear, we want to replace the use of animals in scientific procedures with alternatives where we can, but for now the carefully regulated use of animals in scientific research remains necessary if we are to protect humans and the wider environment. I thank hon. Members once again for their insightful contributions to the debate. I look forward to us working together going forward. Question put and agreed to.
16 Jun 2025 · Animal Experiments: Medical Research · Hansard source
More
I thank my hon. Friend the Member for North Ayrshire and Arran (Irene Campbell) for opening this important debate, and I thank all hon. Members for their contributions. We appreciate that the use of animals in medical research stirs the strong emotional instincts of many people across the UK, including many colleagues here. The day when we can finally bring an end to animal testing cannot come soon enough. Sadly, however, that day is not here yet. Phasing out animal testing has to be done in lockstep with the development of safe, accurate and validated alternatives. The reality is that the technology is not yet advanced enough for alternative methods to completely replace the use of animals. Consequently, the carefully regulated use of animals remains necessary to protect humans and the wider environment. Animal testing continues to be required by international agreements, which all global medicines regulators follow, including the UK’s Medicines and Healthcare products Regulatory Agency. Such testing is regulated through the Animals (Scientific Procedures) Act 1986, known as ASPA. The Act specifies that animals can only be used in science for specific, limited purposes where there are no alternatives, where the number of animals used is the minimum needed to achieve the scientific benefit, and where the potential harm to the animals is limited to the absolute minimum. This is known as the three Rs: replacement, reduction and refinement. The system also includes a three-tier system of licensing that licenses each establishment, project and individual involved in performing regulated procedures involving animals. New technologies including AI, as referred to by colleagues, do offer potentially revolutionary ways to create alternative technologies. That is why our manifesto commits us to partnering with scientists, industry and civil society as we work towards the phasing out of animal testing. As the first step, we will publish a strategy later this year laying out how the Government will support the development, validation and uptake of alternative methods, and officials are working on this as we speak. The strategy will set out how we will create a research and innovation system that replaces animals with alternative methods wherever possible and that places the UK at the forefront of international efforts to drive this agenda. I am proud to say that the UK is already world-leading in the development of alternative methods, and we are keen to utilise this technology as much as possible.
14 May 2025 · Artificial Intelligence: Environmental Impact · Hansard source
More
DSIT works closely with other Departments, including the Department for Energy Security and Net Zero and the Department for Environment, Food and Rural Affairs, to align AI energy demand with future energy planning to ensure long-term sustainability. We understand that AI is an energy-hungry technology, which is why we have set up the AI energy council. Through that council, we are assessing ways to address the growing energy demands of AI and AI sustainability, including by exploring bold clean energy solutions, from next generation renewables to small modular reactors.
14 May 2025 · Artificial Intelligence: Environmental Impact · Hansard source
More
I assure my hon. Friend that the Government are committed to ensuring that AI development aligns with sustainability goals. We welcome the advances in cooling technologies, such as dry cooling and closed-loop systems, in addition to promoting the use of renewable energy resources. I chair the AI Ministers group, which brings together Ministers from all Departments to co-ordinate cross-cutting challenges, including water consumption.
14 May 2025 · Artificial Intelligence: Environmental Impact · Hansard source
More
As I have set out, we have inter-ministerial meetings that bring Ministers together, including Ministers from DEFRA. The Secretary of State regularly meets representatives from the National Farmers Union and other Secretaries of State to discuss these issues.
28 Apr 2025 · Scientific and Regulatory Procedures: Use of Dogs · Hansard source
More
My hon. Friend intervenes at the right time, as I was about to say that in publishing our road map, we will be setting out how we can go even further in supporting alternative methods and working towards a world where the use of animals in science is eliminated in all but exceptional circumstances. That will be achieved by creating a research and innovation system that replaces animals with alternatives wherever possible. Currently, through UKRI, the Government support the development and dissemination of the three Rs. That is achieved primarily through funding for the National Centre for the Replacement, Refinement and Reduction of Animals in Research, which works nationally and internationally to drive the uptake of alternative technologies and to ensure that advances are reflected in policy, practice and regulations on animal research.
28 Apr 2025 · Scientific and Regulatory Procedures: Use of Dogs · Hansard source
More
It is a pleasure to serve under your chairmanship, Ms Jardine. I thank my hon. Friend the Member for North Ayrshire and Arran (Irene Campbell) for opening this important debate. I also thank the thousands of petitioners—some of whom are in the Public Gallery, which indicates the strength of public views on this matter—and all hon. Members here today, who have made powerful contributions. I do not have a dog, so I will not enter the competition about whose dog is the cutest, but I do have two little children who try to touch every single dog we come across when we go around parks; they at least now know that they have to ask permission before they do that. I feel that I am not too far from having one of those cute dogs, or one like Frank, in our household. The Government fully appreciate that the use of dogs for scientific and regulatory procedures stirs strong emotional feelings for many people across the UK, including myself as a dog lover. In my previous role in local government, I was responsible for environment, including stray dogs, as part of a service for many authorities around us. In a bid to avoid having to put healthy dogs down, we set up London’s first dog hotel, which Peter Egan opened. We had a system where staff could come and take dogs out for walks. Every role I have had has involved looking after dogs, and I must say that I found the preparation for this debate very difficult. Along with other Members present, I long for the day when we can finally bring an end to animal testing and the use of dogs in scientific research; it cannot come soon enough, but sadly it is not yet here. The UK is world leading in the development of non-animal methods, and the Government are keen to ensure that those are utilised wherever possible. That is why our manifesto commits us to partner with scientists, industry and civil society as we work towards phasing out animal testing. Colleagues mentioned the changes that the FDA has brought forward. To be clear, those bring it in line with us regarding the protection of animals, but where there is new learning to be done, we will absolutely look at that. As part of our commitment to phasing out the use of animals in science, we will publish a strategy to support the development, validation and uptake of alternative methods. It will set out how we can build on our support by creating a research and innovation system that replaces animal testing with alternative methods wherever possible. However, for now, the carefully regulated use of animals, including dogs, in scientific research remains necessary to protect humans and the wider environment. I will now expand on why, given the current state of science, we are unfortunately not yet ready to ban the use of dogs for testing and research purposes in the UK. The use of animals in science lies in the intersection of two vital public goods: the benefits to humans, animals and the environment, and the UK’s proud history of support for the highest possible standards of animal welfare. The balance between these two public goods is reflected in the UK’s robust regulation of the use of animals in science through the Animals (Scientific Procedures) Act 1986, known as ASPA. The Act specifies that animals can be used in science only for specific limited purposes where there are no alternatives, where the number of animals used is the minimum needed to achieve the scientific benefit and where the potential harm to animals is limited to the absolute minimum. As has been mentioned, this is known as the three Rs: replacement, reduction and refinement. The use of animals in science is therefore highly regulated, including through a three-tier system of licensing, which licenses each establishment, project and individual involved in performing regulated procedures involving animals. All establishments are required to have dedicated individuals, including veterinary surgeons with legal responsibilities for the care and welfare of animals, and an ethical review body that reviews any proposals for the use of animals and promotes the three Rs of animal use. Our manifesto commitment stands in recognition of the fact that the phasing out of animal testing has to be in lockstep with the development of alternatives. As yet, the reality is that the technology is not advanced enough for alternative methods to completely replace the use of animals. For now, animal testing and research play an important role in supporting the development of new medicines and cutting-edge medical technologies for humans and animals, and it supports the safety and sustainability of our environment. Animal research has helped us to make life-changing discoveries, from new vaccines and medicines to transplant procedures, anaesthetics and blood transfusions. The development of the covid-19 vaccine, as with all vaccines, was made possible only because of the use of animals in research. Animals are used to assess how potential new medicines affect biological systems, ensuring that drugs are safe and effective before human trials. Many products that would be unsafe or ineffective, or that could cause harm to humans, are detected through animal testing, ensuring the safety of the healthy volunteers who take part in clinical trials, as well as of future patients.
28 Apr 2025 · Scientific and Regulatory Procedures: Use of Dogs · Hansard source
More
The stats that I have say that in 2023 the use of dogs in procedures reduced by 9%. On overall animal testing, I will have to get back to my hon. Friend. I am sure that my colleagues from the Home Office will be able to explain the stringent licensing process—the procedure that everyone has to go through to be able to obtain a licence. We want to replace the use of animals in scientific procedures with alternatives where we can. That is why our current approach is to support and fund the development and dissemination of techniques that replace, reduce and refine the use of animals in research, and to ensure that the UK has a robust regulatory system for licensing animal studies and enforcing legal standards, which will drive their uptake. We have a commitment in our manifesto to do all we can to phase out the use of animals—including dogs—in science, and we will be publishing a road map before the end of the year to lay out how we can give increased impetus to the support and validation of alternative methods. Colleagues asked about ensuring that we are consulting animal welfare organisations, and there is a roundtable meeting with the Office for Life Sciences and animal welfare organisations to do precisely that. The hon. Member for Winchester (Dr Chambers) requested a meeting to discuss issues around the benefits of testing on animals. I am happy to agree to that and will be in contact with his office to arrange one. I conclude by again thanking Members for their insightful contributions to today’s debate, and I look forward to working together as we go forward.
28 Apr 2025 · Scientific and Regulatory Procedures: Use of Dogs · Hansard source
More
I thank the hon. Member for that intervention, and I am happy to share the research and reasons behind my arguments. For the reasons I have given, animal testing is required by the international agreements followed by all global medicines regulators, including the UK’s Medicines and Healthcare products Regulatory Agency. Although the MHRA does not require all medicines to be tested on two species, safety testing in a second species is required for most drugs, with dogs being one of the species that can be used. The key proposal in the petition is for an immediate ban on the use of dogs in scientific and regulatory procedures. None of us wants dogs to be used in research, despite how carefully animal welfare is regulated. However, I regret to say that forbidding the use of dogs in medical research—without alternatives at the moment—would likely have catastrophic effects on the UK’s medical research system. We would be unable to meet international regulatory requirements for drug safety testing, preventing virtually all first-in-human trials in the UK and vastly reducing the number of subsequent clinical trials. A significant proportion of basic research would cease, preventing new insight into disease and treatments that save lives and improve people’s health. Forbidding the use of animals in medical research would also likely have a negative impact on animal welfare. Animal testing would move overseas, to countries where the regulations on the use of animals in science are less stringent than they are here. I am proud to say that the UK is world leading in the development of alternative methods, and we are keen to utilise that technology as much as possible. As much as we can, we are striving to partner with regulators to see how advances in technology can phase out animal use where we are able to do that.
3 Apr 2025 · UK Democracy: Impact of Digital Platforms · Hansard source
More
I thank the hon. Member for Lagan Valley (Sorcha Eastwood) for securing the debate. I join her in honouring the memory of our dear colleagues Sir David Amess and Jo Cox. I am grateful to her and to all the other speakers for their incredibly powerful and insightful contributions to the debate. The Government share the hon. Member’s concerns about the impact that online harassment, intimidation, abuse, misinformation and disinformation have on our democracy. Existing and emerging technologies have led to changes in the information environment and will continue to shape our future, but it is, and will always be, an absolute priority for the UK Government to protect our democracy, and we remain well-prepared to do so with robust systems in place. I was grateful to the hon. Member for sharing her experiences. The House should hear about the online abuse and hate that she has faced. There is no place for that, and I thank her for sharing it. The Government are committed to combating violence against women and girls. The Online Safety Act requires Ofcom to develop and enforce guidance for tech companies, which aims to ensure that platforms implement measures to reduce harm to women and girls online. The Act imposes legal responsibility on online platforms, including social media platforms, gaming platforms, dating apps and search engines, to protect users from illegal content and material that is harmful to children and to address issues that disproportionately affect women and girls. Those measures reflect the Government’s commitment to creating a safer online environment, acknowledging the unique challenge faced by women and girls in the digital space. In putting that guidance together, Ofcom consulted with the Domestic Abuse Commissioner, the Victims’ Commissioner and experts in the field. The effectiveness of those measures depends on their robust implementation and enforcement, which we will monitor closely. As the hon. Member knows, the implementation of the Online Safety Act started only in spring this year. While we know it is a landmark Act, it is not perfect, so the Government will continue to keep it under review, and we will not shy away from strengthening it where required. As I said, the Act is already being implemented. We will introduce protections to protect people from illegal content, such as child sexual abuse and terrorist material, as well as to protect children from harmful material. I make it clear to the House and to all Members who raised this issue that that is not up for negotiation. The hon. Member also raised the issue of banning smartphones for under-16s. The Government will consider all options in pursuit of children’s online safety. However, it is important that the Government take evidence-based action in recognition of the need to balance safety with allowing children to use technology positively. I am sure she is also aware that in November last year, the Department announced a study using methods and data to understand the impact of smartphones and social media on children. The study began in December last year and will run for six months until May 2025, and I am sure we will report to the House on that. I come back to my right hon. Friend the Member for Oxford East (Anneliese Dodds). I take this opportunity to thank her for all the support she gave me and many of my colleagues when she served on the Front Bench in opposition and when we came into government. I look forward to seeing her on the Front Bench again soon; I hope she does not spend too long on the Back Benches. My right hon. Friend raised the issue of the unrest last year. During that unrest, the Department worked with major platforms to tackle content contributing to the disorder, which included proactively referring content to platforms that assessed and acted on it in line with their terms of service. Throughout our engagement, we have been very clear that social media platforms should not wait for the Online Safety Act to come into action: they should actively be removing harmful content. My right hon. Friend also raised the issue of broader international collaboration on online safety, with which I absolutely agree. International collaboration is absolutely crucial in tackling the global threat of online harms, and we must build consensus around approaches that uphold our democratic values and promote a free, open and secure internet. As the hon. Member for Runnymede and Weybridge (Dr Spencer) said, since 2022, the Elections Act has protected candidates, campaigners and elected office holders from intimidation, both online and in person. It is an election offence for a person to make or publish, before or during an election, a false statement of fact about a candidate’s personal character or conduct, for the purpose of affecting the return for that candidate at the election, if the person does not believe it to be true. This provides a reasonable check and balance against malicious smear campaigns. We also have the defending democracy taskforce, which has a mandate to drive forward a whole-Government response to the full range of threats to our democracy. That taskforce reports to the National Security Council and is comprised of Ministers and senior officials, as well as representatives of law enforcement, the UK intelligence community, the parliamentary authorities and the Electoral Commission. In April 2023, the task- force set up the joint election security and preparedness unit—JESP, for short—as a permanent function dedicated to protecting UK elections and referendums. It monitors and mitigates risks related to the security of elections, including those posed by artificial intelligence, misinformation and disinformation. JESP stood up an election cell for the 2024 elections, which co-ordinated a wide range of teams across Government to respond to issues as they emerged, including issues to do with protective security, cyber-threats, and misinformation and disinformation. An election cell has been stood up for the upcoming local elections. Firm steps are being taken to ensure the security of candidates and campaigners. That happened during last year’s election, and will happen again for the upcoming local elections. Candidates were issued with security advice, and guidance was made available on gov.uk about the risks they face, including from AI and disinformation. That guidance brought together expertise from across the security community, including from the police and the National Cyber Security Centre, to help candidates implement quick and effective personal protective measures. I have only recently looked at that guidance, and I recommend that all candidates take a look. There was also an investment of £31 million over financial year 2024-25 to strengthen protective security measures for MPs, locally elected representatives and candidates. As reported by the Electoral Commission, last year’s UK general election was delivered safely and securely. Certain novel risks, such as AI-generated deepfakes influencing the outcome, did not materialise. However, in that election, there was unacceptable harassment and intimidation directed at candidates—particularly female candidates—and campaigners, especially online. It is clearly vital that everyone, regardless of their sex/gender or race, feels able to participate in public life. The Home Office is reviewing this activity through the defending democracy taskforce. We need to better understand the trends, motivations and drivers that cause people to harass and intimidate their elected representatives. That includes identifying gaps and vulnerabilities and developing recommendations to strengthen legislative responses, as well as a clear delineation of online versus in-person activity and its impact. That work will be reported to the taskforce, and my Department has contributed to these efforts to tackle online harms and improve online environments. While the primary responsibility for harmful social media content rests with the individuals and groups who create and post it, social media platforms have a responsibility to keep users safe.
26 Mar 2025 · Motor Neurone Disease · Hansard source
More
I pay tribute to my hon. Friend for drawing attention to the work of the Mark Sommerville Foundation in this important area. Government funders are investing in MND research to accelerate progress. Let me give just one example. Through UK Research and Innovation and the National Institute for Health and Care Research, the Government are investing £6 million in the MND translational accelerator, led by Dementias Platform UK. The aim of the funded projects is to accelerate the development of treatment for MND.
26 Mar 2025 · Motor Neurone Disease · Hansard source
More
We work closely with the Department of Health and Social Care to support research into this terrible disease. UK Research and Innovation invested £10 million in MND research in 2023-24, and it also plays a key role in funding the underpinning research that benefits medical research more generally. Since 2022, the Medical Research Council and the National Institute for Health and Care Research have awarded £2.8 million to MND projects led by Scottish research organisations.
26 Mar 2025 · Motor Neurone Disease · Hansard source
More
The Government are doing and have done a great deal. We have continued to support this work through both UKRI and the NIHR, and a large amount of funding has gone into clinical research. However, I should be happy to discuss the issue further with the right hon. Gentleman, and to let him know what more work could be done on clinical trials.
24 Mar 2025 · BioNTech UK: Financial Assistance · Hansard source
More
I beg to move, That this House authorises the Secretary of State to undertake to pay, and to pay by way of financial assistance under section 8 of the Industrial Development Act 1982, a grant or grants exceeding £30 million and up to a total of £129 million to BioNTech UK Limited to support their planned expansion of research and development and artificial intelligence activities in the UK over the next 10 years. It is an honour to serve under your chairmanship, Ms Jardine. This investment comes at an important time for the UK’s thriving life sciences sector, which forms a key pillar of two of the Government’s missions: to kick-start economic growth; and to build an NHS fit for the future. The sector is responsible for over £100 billion of turnover in the UK, and it supports over 304,000 jobs in 6,850 businesses. In addition to supporting our economy, the sector also delivers for patients by providing the medicines and technologies that people need to live longer, healthier lives. As we will set out in the life sciences sector plan, we must build on our world-leading R&D ecosystem and double down on rebuilding an internationally competitive business environment so that innovative companies can start, scale and stay here in the UK. To deliver that plan, we will continue to work in partnership with industry, our life sciences ecosystem and the NHS to seize opportunities that will foster innovation across the UK. To that end, through this proposed grant, we have an opportunity for the UK to secure international investment in innovative, cutting-edge R&D in the face of increasing global competition. As the right hon. and hon. Members present know, BioNTech is an international leader in the biotechnology industry, and the developer of the first licensed mRNA covid-19 vaccine. Building on the vaccine’s success and global impact, BioNTech has applied for a Government grant of £129 million to support its transformation and UK expansion, which will see it invest circa £1 billion over 10 years. Supported by the grant, BioNTech research activities will focus on structural biology, regenerative medicine, oncology and AI-driven drug discovery, spanning three locations and creating about 460 new, directly-employed, highly skilled jobs. In Cambridge, BioNTech will set up a new centre of excellence to focus on drug discovery and development of new treatments for cancer and other serious diseases. That directly supports the Government’s ambition to boost the Oxford-Cambridge growth corridor. In London, BioNTech intends to establish a major hub, including a centre of AI expertise to leverage this game-changing technology and to enhance our understanding of diseases, their causes and drug targeting. At a third site—to be announced shortly—BioNTech plans to undertake R&D into vaccines, including for diseases with high pandemic potential. BioNTech’s decision to invest in the UK and to expand its R&D activities builds on the Government’s existing strategic partnership with the company. That includes BioNTech’s work to provide up to 10,000 NHS patients with personalised immunotherapies by 2030, which is already transforming health outcomes by enabling UK patients to be among the first in the world to benefit from cancer vaccines. That support for BioNTech is further evidence of the Government’s backing of a world-leading life sciences sector. Working together, we are driving growth, creating jobs and fostering innovation that will translate into positive outcomes for patients. Supporting BioNTech’s investment is another signal of our commitment to this crucial sector ahead of launching our ambitious life sciences sector plan in the spring. I commend the motion to the Committee.
24 Mar 2025 · BioNTech UK: Financial Assistance · Hansard source
More
I thank the Opposition and Liberal Democrat spokespeople. The funding we have discussed today will unlock around £1 billion to further boost the UK’s life sciences sector and, in turn, support the Government’s missions to kick-start economic growth and build an NHS fit for the future. It will also build on our significant progress and commitments to date, including the life sciences innovative manufacturing fund of up to £520 million announced by the Chancellor in October 2024, and our landmark partnerships with Oxford Nanopore and Eli Lilly. The hon. Member for Runnymede and Weybridge (Dr Spencer) commented on the investment environment. I am sure he did not miss the fact that this Government attracted £63 billion-worth of investment at the last international investment summit. We have done the hard work to make that investment a reality. He may be interested to hear that, according to the latest CEO survey by PricewaterhouseCoopers, the UK is the second best country in the world in which to invest. However, we are not complacent, and we are fully committed to making the UK the best place to invest. The life sciences are an area of huge UK expertise, and they are key to that commitment. Securing this investment will send a clear message to innovative companies that the UK is open for business. The hon. Member for Harpenden and Berkhamsted (Victoria Collins) asked about monitoring. The financial assistance will be monitored through the normal procedures used for any investment made by the Government. I am happy to send her details of that process and the timeline for this investment. Working together with industry, this Government are delivering better patient outcomes and driving economic growth. I look forward to continuing that work, and to building on that momentum through the publication and rapid delivery of the life sciences sector plan and industrial strategy in the spring. I commend the motion to the Committee. Question put and agreed to .

Published records only — not a full account of an MP’s work. How we work →